| 12227520 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +9 more |
2025-02-18 |
|
| 12187734 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2025-01-07 |
|
| 12180197 |
GLP-1R modulating compounds |
Gediminas Brizgys, Chienhung Chou, Jeromy J. Cottell, Chao-I Hung, Scott D. Schroeder +5 more |
2024-12-31 |
$374,549,000 |
| 12162844 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2024-12-10 |
$252,679,000 |
| 12161625 |
Substituted pyrrolizine compounds and uses thereof |
Jinfa Du, Joshua A. Kaplan, Thorsten A. Kirschberg, Tetsuya Kobayashi, Scott E. Lazerwith +7 more |
2024-12-10 |
$252,679,000 |
| 12122776 |
Tetracyclic compounds and uses thereof |
Lan Jiang, David W. Lin, Ezra Roberts, Gregg M. Schwarzwalder |
2024-10-22 |
$144,823,000 |
| 12091404 |
GLP-1R modulating compounds |
Gediminas Brizgys, Chienhung Chou, Jeromy J. Cottell, Chao-I Hung, James G. Taylor +4 more |
2024-09-17 |
$320,643,000 |
| 12070455 |
Thienopyrrole compounds |
Stephen E. Ammann, Eda Canales, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith +3 more |
2024-08-27 |
$638,061,000 |
| 11897892 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2024-02-13 |
$118,355,000 |
| 11878965 |
Inhibitors of peptidylarginine deiminases |
Daniel H. Byun, Zhenhong R. Cai, Eda Canales, Laurent P. Debien, Timothy R. Hansen +13 more |
2024-01-23 |
$552,258,000 |
| 11858918 |
GLP-1R modulating compounds |
Megan K. Armstrong, James S. Cassidy, Elbert Chin, Chienhung Chou, Jeromy J. Cottell +10 more |
2024-01-02 |
$573,165,000 |
| 11697652 |
Tetracyclic compounds and uses thereof |
Lan Jiang, David W. Lin, Ezra Roberts, Gregg M. Schwarzwalder |
2023-07-11 |
$267,739,000 |
| 11661431 |
Thienopyrrole compounds |
Stephen E. Ammann, Eda Canales, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith +4 more |
2023-05-30 |
$275,933,000 |
| 11643400 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2023-05-09 |
$305,124,000 |
| 11613546 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2023-03-28 |
$310,764,000 |
| 11548902 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +9 more |
2023-01-10 |
$214,003,000 |
| 11352371 |
Thienopyrimidine derivatives as ACC inhibitors and uses thereof |
Jamie Geier Bates, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Brian Kirby +4 more |
2022-06-07 |
$208,963,000 |
| 11084832 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +9 more |
2021-08-10 |
$462,351,000 |
| 10988451 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2021-04-27 |
$236,030,000 |
| 10874640 |
Substituted pyrrolizine compounds and uses thereof |
Jinfa Du, Joshua A. Kaplan, Thorsten A. Kirschberg, Tetsuya Kobayashi, Scott E. Lazerwith +7 more |
2020-12-29 |
$340,625,000 |
| 10800772 |
Therapeutic compounds |
Zhenhong R. Cai, Hongyan Guo, Mingzhe Ji, Haolun Jin, Amy S. Lee +5 more |
2020-10-13 |
$741,702,000 |
| 10703733 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2020-07-07 |
$851,015,000 |
| 10328053 |
Substituted pyrrolizine compounds and uses thereof |
Jinfa Du, Joshua A. Kaplan, Thorsten A. Kirschberg, Tetsuya Kobayashi, Scott E. Lazerwith +7 more |
2019-06-25 |
$200,079,000 |
| 9981955 |
Antiviral compounds |
Elizabeth M. Bacon, Eda Canales, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai +23 more |
2018-05-29 |
|
| 9879023 |
Therapeutic compounds |
Kerim Babaoglu, Ryan McFadden, Paul A. Roethle, Lianhong Xu, Hong Yang |
2018-01-30 |
$266,323,000 |
